64 results
Page 3 of 4
DEFM14A
lxjzp91wig 90
21 Dec 18
Proxy related to merger
12:23pm
PREM14A
ty3yf2uk xucv
11 Dec 18
Preliminary proxy related to merger
5:23pm
8-K
EX-10.1
wt6n8ypa
14 Nov 18
Entry into a Material Definitive Agreement
12:53pm
8-K
EX-99.1
bqyyv9h fu43
14 Aug 18
Avenue Therapeutics Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights
9:00am
8-K
EX-99.1
xyihg8h
21 May 18
Avenue Therapeutics Announces Positive Topline Phase 3 Data for Intravenous Tramadol in the Management of Postoperative Pain
8:15am
8-K
EX-99.1
f30ehwdqvwvls57prx2d
3 May 18
Avenue Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights
8:00am
DEF 14A
r25cmoq037u0eq w43
30 Apr 18
Definitive proxy
7:02am
10-K
1t9 mhwrw81ef2ajw23y
1 Mar 18
Annual report
12:00am
10-Q
5qj rz7b4goy
12 May 17
Quarterly report
12:00am
10-12G/A
i67nf
13 Mar 17
Registration of securities (amended)
12:00am
10-12G/A
na05dr ylzd
6 Mar 17
Registration of securities (amended)
12:00am
10-12G
EX-10.6
n3m2uqr
12 Jan 17
Registration of securities
12:00am
10-12G
dq03ttn9dvk38o1
12 Jan 17
Registration of securities
12:00am
10-12G
EX-10.7
hgfmj4iaj9672
12 Jan 17
Registration of securities
12:00am